![Bob Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Huang
Directeur/Bestuurslid bij
Travecta Therapeutics Pte Ltd.
Profiel
Bob Huang is currently the Director at Travecta Therapeutics Pte Ltd. and Investment Director at Seidler Equity Australia.
He holds a doctorate from The University of New South Wales and an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Bob Huang
| Bedrijven | Functie | Begin |
|---|---|---|
Seidler Equity Australia
 Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01-01-2017 |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Directeur/Bestuurslid | 27-10-2021 |
Opleiding van Bob Huang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Technology Services |
Seidler Equity Australia
Seidler Equity Australia Investment ManagersFinance Acts as an alternative investment manager | Finance |
